Karp Barbara Illowsky
National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, Maryland 20892, USA.
Mov Disord. 2004 Mar;19 Suppl 8:S116-9. doi: 10.1002/mds.20025.
Botulinum toxin is now the first-line therapy for writer's cramp and other occupational dystonias, with well-established efficacy and safety. Future studies will allow us to understand better the physiological effects of injection and to refine and enhance our treatment of focal hand dystonia.
肉毒杆菌毒素目前是书写痉挛和其他职业性肌张力障碍的一线治疗方法，其疗效和安全性已得到充分证实。未来的研究将使我们能够更好地理解注射的生理效应，并改进和加强我们对局灶性手部肌张力障碍的治疗。
